Trial Profile
Comparison of 10 days of monotherapy with tenofovir alafenamide 8, 25 and 40 mg/day and tenofovir disoproxil fumarate 300mg in patients with HIV-1 infections
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Sep 2015
Price :
$35
*
At a glance
- Drugs Tenofovir alafenamide (Primary) ; Tenofovir disoproxil fumarate
- Indications HIV-1 infections
- Focus Therapeutic Use
- Sponsors Gilead Sciences
- 05 Apr 2012 New trial record